0001022079-23-000035.txt : 20230227 0001022079-23-000035.hdr.sgml : 20230227 20230227164919 ACCESSION NUMBER: 0001022079-23-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230223 FILED AS OF DATE: 20230227 DATE AS OF CHANGE: 20230227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E CENTRAL INDEX KEY: 0001222679 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 23675989 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_167753453710712.xml FORM 4 X0306 4 2023-02-23 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001222679 PREVOZNIK MICHAEL E 500 PLAZA DRIVE SECAUCUS NJ 07094 0 1 0 0 SVP & General Counsel Common Stock 2023-02-23 4 F 0 811 147.86 D 38413 D Common Stock 2023-02-23 4 A 0 2442 0 A 40855 D Common Stock 2023-02-24 4 S 0 1415 141.42 D 39440 D Common Stock 5411 I 401(k)/SDCP Non-Qualifed Stock Option (right to buy) 143.33 2023-02-23 4 A 0 9653 0 A 2033-02-23 Common Stock 9653.0 9653 D Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Represents an award of restricted share units. The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 27, 2022. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Michael E. Prevoznik 2023-02-27